Europe finances a genome-sequencing project on hypermutated tumours
Diario Médico has echoed that Fran Supek, head of the IRB Barcelona Genome Data Science group, has been awarded a Starting Grant from the European Research Council (ERC). This funding will be used to further his project. Supek aims to acquire greater knowledge of cancer biology in order to support the design of individualised therapies. To this end, he will analyse hypermutated tumours.
Link to Diario Médico
Related content
News
Modesto Orozco’s lab has published a paper in Chemical Communications about a therapeutic tool to prevent treatment resistance in breast cancer.
The tool has been tested in tumour cells in vitro and will now need to be tested in animal models before moving on to the development of a valid treatment for patients.
Muy Interesante, El Punt AVui, Diario Médico, Laboratory Journal and Federfarma, among other national and international media, have published articles about the research led by Núria López-Bigas, ICREA researcher at IRB Barcelona and that explains the origin of the mysterious periodicity in the genome.
Link to Muy Interesante
IRB Barcelona has been awarded two ERC PoC grants to optimise and validate tools with potential clinical applications.
Angel R. Nebreda’s project seeks to develop treatments to reduce the cardiotoxicity caused by chemotherapy.
Eduard Batlle’s project will build a biobank of mouse tumour organoids with the aim to contribute to the treatment of patients with advanced colon cancer.
